Moreover, Laura Bergantini and her colleagues demonstrated that therapeutic intervention with anti-IL-5 elicits a restorative equilibrium between regulatory T cells and effector T cells within the pulmonary microenvironment of individuals afflicted with severe asthma (86). Here, IL5 is linked to asthma.